Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets

Molecular Aspects of Medicine

Volumn 39, Issue , 2014, Pages 110-125

  Ahmed, Nuzhat ^a,b,c   Abubaker, Khalid ^a,b   Findlay, Jock K ^a,b,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Chemoresistance; Ovarian carcinoma; Recurrence; Stem cell markers

Indexed keywords

CA 125 ANTIGEN; CD133 ANTIGEN; CD24 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 6; KI 67 ANTIGEN; MICRORNA; MICRORNA 1181; MICRORNA 1202; MICRORNA 146A; MICRORNA 200A; MICRORNA 200B; MICRORNA 205; MICRORNA 23B; MICRORNA 27A; MICRORNA 27B; MICRORNA 346; MICRORNA 424; MICRORNA 503; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; STAT3 PROTEIN; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; AUTOCRINE EFFECT; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL RENEWAL; CELL STRESS; CELL SURVIVAL; DISEASE MARKER; DNA DAMAGE; DOWN REGULATION; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; OVARY TUMOR; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; REVIEW; STEM CELL NICHE; TREATMENT OUTCOME; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UPREGULATION; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR RECURRENCE;

ANIMALS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS;

EID: 84906963524     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2013.06.002     Document Type: Review

References (140)

1. S. Abelson, Y. Shamai, L. Berger, R. Shouval, K. Skorecki, and M. Tzukerman Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer Stem Cells 30 3 2012 415 424
2. K. Abubaker, A. Latifi, R. Luwor, S. Nazaretian, H. Zhu, M.A. Quinn, E.W. Thompson, J.K. Findlay, and N. Ahmed Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden Mol. Cancer 12 2013 24
3. C. Aguilar-Gallardo, E.C. Rutledge, A.M. Martinez-Arroyo, J.J. Hidalgo, S. Domingo, and C. Simon Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches Stem Cell Rev. 8 3 2012 994 1010
4. N. Ahmed, S. Maines-Bandiera, M.A. Quinn, W.G. Unger, S. Dedhar, and N. Auersperg Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium Am. J. Physiol. Cell Physiol. 290 6 2006 C1532 1542
5. N. Ahmed, E.W. Thompson, and M.A. Quinn Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm J. Cell Physiol. 213 3 2007 581 588
6. N. Ahmed, K. Abubaker, J. Findlay, and M. Quinn Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer Curr. Cancer Drug Targets 10 3 2010 268 278
7. N. Ahmed, K. Abubaker, J. Findlay, and M. Quinn Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance J. Cell Biochem. 114 1 2013 21 34
8. G.K. Alderton Tumour heterogeneity: the rise of the minority Nat. Rev. Cancer 13 4 2013 225
9. G.D. Aletti, M.M. Gallenberg, W.A. Cliby, A. Jatoi, and L.C. Hartmann Current management strategies for ovarian cancer Mayo Clin. Proc. 82 6 2007 751 770
10. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Nat. Acad. Sci. USA 100 7 2003 3983 3988
11. A.B. Alvero, R. Chen, H.H. Fu, M. Montagna, P.E. Schwartz, T. Rutherford, D.A. Silasi, K.D. Steffensen, M. Waldstrom, I. Visintin, and G. Mor Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance Cell Cycle 8 1 2009 158 166
12. A.B. Alvero, H.H. Fu, J. Holmberg, I. Visintin, L. Mor, C.C. Marquina, J. Oidtman, D.A. Silasi, and G. Mor Stem-like ovarian cancer cells can serve as tumor vascular progenitors Stem Cells 27 10 2009 2405 2413
13. A. Amsterdam, C. Raanan, L. Schreiber, O. Freyhan, L. Schechtman, and I.D. Givo Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship Acta Histochem. 115 4 2013 330 338
14. N. Auersperg, S.L. Maines-Bandiera, H.G. Dyck, and P.A. Kruk Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes Lab Invest. 71 4 1994 510 518
15. N. Auersperg, A.S. Wong, K.C. Choi, S.K. Kang, and P.C. Leung Ovarian surface epithelium: biology, endocrinology, and pathology Endocr. Rev. 22 2 2001 255 288
16. A. Bamias, S. Pignata, and E. Pujade-Lauraine Angiogenesis: a promising therapeutic target for ovarian cancer Crit. Rev. Oncol. Hematol. 84 3 2012 314 326
17. S.A. Bapat, A.M. Mali, C.B. Koppikar, and N.K. Kurrey Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Res. 65 8 2005 3025 3029
18. M.V. Barbolina, N.M. Moss, S.D. Westfall, Y. Liu, R.J. Burkhalter, F. Marga, G. Forgacs, L.G. Hudson, and M.S. Stack Microenvironmental regulation of ovarian cancer metastasis Cancer Treat Res. 149 2009 319 334
19. N. Barker, J.H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. Cozijnsen, A. Haegebarth, J. Korving, H. Begthel, P.J. Peters, and H. Clevers Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 449 7165 2007 1003 1007
20. D.A. Bell Origins and molecular pathology of ovarian cancer Mod. Pathol. 18 Suppl 2 2005 S19 32
21. A.C. Berardi, A. Wang, J.D. Levine, P. Lopez, and D.T. Scadden Functional isolation and characterization of human hematopoietic stem cells Science 267 5194 1995 104 108
22. D. Bhartiya, K. Sriraman, and S. Parte Stem cell interaction with somatic niche may hold the key to fertility restoration in cancer patients Obstet. Gynecol. Int. 2012 2012 921082
23. C. Blanpain, V. Horsley, and E. Fuchs Epithelial stem cells: turning over new leaves Cell 128 3 2007 445 458
24. E.R. Blazek, J.L. Foutch, and G. Maki Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia Int. J. Radiat. Oncol. Biol. Phys. 67 1 2007 1 5
25. T. Borovski, E.M.F. De Sousa, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res. 71 3 2011 634 639
26. L.Y. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells J. Biol. Chem. 283 25 2008 17635 17651
27. N.J. Bowen, L.D. Walker, L.V. Matyunina, S. Logani, K.A. Totten, B.B. Benigno, and J.F. McDonald Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells BMC Med. Genomics 2 2009 71
28. T. Brabletz EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22 6 2012 699 701
29. D. Burgos-Ojeda, B.R. Rueda, and R.J. Buckanovich Ovarian cancer stem cell markers: prognostic and therapeutic implications Cancer Lett. 322 1 2012 1 7
30. K.M. Burleson, L.K. Hansen, and A.P. Skubitz Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers Clin. Exp. Metastasis 21 8 2004 685 697
31. K.M. Burleson, M.P. Boente, S.E. Pambuccian, and A.P. Skubitz Disaggregation and invasion of ovarian carcinoma ascites spheroids J. Transl. Med. 4 2006 6
32. S.M. Cabarcas, L.A. Mathews, and W.L. Farrar The cancer stem cell niche-there goes the neighborhood? Int. J. Cancer 129 10 2011 2315 2327
33. J. Cai, H. Tang, L. Xu, X. Wang, C. Yang, S. Ruan, J. Guo, S. Hu, and Z. Wang Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness Carcinogenesis 33 1 2012 20 29
34. C. Calabrese, H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, B. Hamner, E.Y. Oh, M.W. Gaber, D. Finklestein, M. Allen, A. Frank, I.T. Bayazitov, S.S. Zakharenko, A. Gajjar, A. Davidoff, and R.J. Gilbertson A perivascular niche for brain tumor stem cells Cancer Cell 11 1 2007 69 82
35. L. Cao, M. Shao, J. Schilder, T. Guise, K.S. Mohammad, and D. Matei Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer Oncogene 31 20 2012 2521 2534
36. O. Celik, E. Celik, I. Turkcuoglu, E. Yilmaz, Y. Simsek, and B. Tiras Germline cells in ovarian surface epithelium of mammalians: a promising notion Reprod. Biol. Endocrinol. 10 2012 112
37. W.K. Chau, C.K. Ip, A.S. Mak, H.C. Lai, and A.S. Wong C-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling Oncogene 32 22 2012 2767 2781
38. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, S.G. Kernie, and L.F. Parada A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 7412 2012 522 526
39. W. Cheng, T. Liu, X. Wan, Y. Gao, and H. Wang MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells FEBS J 279 11 2012 2047 2059
40. I. Conic, I. Dimov, D. Tasic-Dimov, B. Djordjevic, and V. Stefanovic Ovarian epithelial cancer stem cells Sci. World J. 11 2011 1243 1269
41. M.D. Curley, L.A. Garrett, J.O. Schorge, R. Foster, and B.R. Rueda Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer Front Biosci 16 2011 368 392
42. B. Desoize, and J. Jardillier Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36 2-3 2000 193 207
43. G. Driessens, B. Beck, A. Caauwe, B.D. Simons, and C. Blanpain Defining the mode of tumour growth by clonal analysis Nature 488 7412 2012 527 530
44. Z. Duan, R. Foster, D.A. Bell, J. Mahoney, K. Wolak, A. Vaidya, C. Hampel, H. Lee, and M.V. Seiden Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer Clin. Cancer Res. 12 17 2006 5055 5063
45. L. Dubeau The cell of origin of ovarian epithelial tumours Lancet Oncol. 9 12 2008 1191 1197
46. N. Dumont, M.B. Wilson, Y.G. Crawford, P.A. Reynolds, M. Sigaroudinia, and T.D. Tlsty Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers Proc. Nat. Acad. Sci. USA 105 39 2008 14867 14872
47. C. Emmanuel, N. Gava, C. Kennedy, R.L. Balleine, R. Sharma, G. Wain, A. Brand, R. Hogg, D. Etemadmoghadam, J. George, M.J. Birrer, C.L. Clarke, G. Chenevix-Trench, D.D. Bowtell, P.R. Harnett, and A. deFazio Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis PLoS One 6 3 2011 e17617
48. G. Ferrandina, G. Bonanno, L. Pierelli, A. Perillo, A. Procoli, A. Mariotti, M. Corallo, E. Martinelli, S. Rutella, A. Paglia, G. Zannoni, S. Mancuso, and G. Scambia Expression of CD133-1 and CD133-2 in ovarian cancer Int. J. Gynecol. Cancer 18 3 2008 506 514
49. A. Flesken-Nikitin, C.I. Hwang, C.Y. Cheng, T.V. Michurina, G. Enikolopov, and A.Y. Nikitin Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche Nature 495 7440 2013 241 245
50. A.K. Folkins, A. Saleemuddin, L.A. Garrett, J.E. Garber, M.G. Muto, S.S. Tworoger, and C.P. Crum Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer Gynecol. Oncol. 115 1 2009 108 111
51. M.Q. Gao, Y.P. Choi, S. Kang, J.H. Youn, and N.H. Cho CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells Oncogene 29 18 2010 2672 2680
52. P. Hamerlik, J.D. Lathia, R. Rasmussen, Q. Wu, J. Bartkova, M. Lee, P. Moudry, J. Bartek Jr., W. Fischer, J. Lukas, J.N. Rich, and J. Bartek Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth J. Exp. Med. 209 3 2012 507 520
53. J.M. Heddleston, Z. Li, J.D. Lathia, S. Bao, A.B. Hjelmeland, and J.N. Rich Hypoxia inducible factors in cancer stem cells Br. J. Cancer 102 5 2010 789 795
54. A. Helland, M.S. Anglesio, J. George, P.A. Cowin, C.N. Johnstone, C.M. House, K.E. Sheppard, D. Etemadmoghadam, N. Melnyk, A.K. Rustgi, W.A. Phillips, H. Johnsen, R. Holm, G.B. Kristensen, M.J. Birrer, R.B. Pearson, A.L. Borresen-Dale, D.G. Huntsman, A. deFazio, C.J. Creighton, G.K. Smyth, and D.D. Bowtell Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers PLoS One 6 4 2011 e18064
55. B.G. Hollier, K. Evans, and S.A. Mani The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies J. Mammary Gland Biol. Neoplasia 14 1 2009 29 43
56. L.G. Hudson, R. Zeineldin, and M.S. Stack Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression Clin. Exp. Metastasis 25 6 2008 643 655
57. Integrated genomic analyses of ovarian carcinoma. 2011 Nature 474 (7353):609-615.
58. A.A. Jazaeri, J.L. Bryant, H. Park, H. Li, N. Dahiya, M.H. Stoler, J.S. Ferriss, and A. Dutta Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma Neoplasia 13 10 2011 899 911
59. T. Jazedje, P.M. Perin, C.E. Czeresnia, M. Maluf, S. Halpern, M. Secco, D.F. Bueno, N.M. Vieira, E. Zucconi, and M. Zatz Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures J. Trans. Med. 7 2009 46
60. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J. Clin. 59 4 2009 225 249
61. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, A. Nawa, and F. Kikkawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int. J. Oncol. 31 2 2007 277 283
62. A.M. Karst, and R. Drapkin Ovarian cancer pathogenesis: a model in evolution J. Oncol. 2010 2010 932371
63. A.M. Karst, K. Levanon, and R. Drapkin Modeling high-grade serous ovarian carcinogenesis from the fallopian tube Proc. Nat. Acad. Sci. USA 108 18 2011 7547 7552
64. S. Keller, A.K. Konig, F. Marme, S. Runz, S. Wolterink, D. Koensgen, A. Mustea, J. Sehouli, and P. Altevogt Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes Cancer Lett. 278 1 2009 73 81
65. P.N. Kelly, A. Dakic, J.M. Adams, S.L. Nutt, and A. Strasser Tumor growth need not be driven by rare cancer stem cells Science 317 5836 2007 337
66. E. Kipps, D.S. Tan, and S.B. Kaye Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research Nat. Rev. Cancer 13 4 2013 273 282
67. S.Y. Ko, N. Barengo, A. Ladanyi, J.S. Lee, F. Marini, E. Lengyel, and H. Naora HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts J. Clin. Invest. 122 10 2012 3603 3617
68. E. Kuhn, R.J. Kurman, and I.M. Shih Ovarian cancer is an imported disease: fact or fiction? Curr. Obstet. Gynecol. Rep. 1 1 2012 1 9
69. N.K. Kurrey, S.P. Jalgaonkar, A.V. Joglekar, A.D. Ghanate, P.D. Chaskar, R.Y. Doiphode, and S.A. Bapat Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells Stem Cells 27 9 2009 2059 2068
70. M.J. Kwon, and Y.K. Shin Regulation of ovarian cancer stem cells or tumor-initiating cells Int. J. Mol. Sci. 14 4 2013 6624 6648
71. C.N. Landen Jr., B. Goodman, A.A. Katre, A.D. Steg, A.M. Nick, R.L. Stone, L.D. Miller, P.V. Mejia, N.B. Jennings, D.M. Gershenson, R.C. Bast Jr., R.L. Coleman, G. Lopez-Berestein, and A.K. Sood Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol. Cancer Ther. 9 12 2010 3186 3199
72. A. Latifi, K. Abubaker, N. Castrechini, A.C. Ward, C. Liongue, F. Dobill, J. Kumar, E.W. Thompson, M.A. Quinn, J.K. Findlay, and N. Ahmed Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J. Cell Biochem. 112 2011 2850 2864
73. A. Latifi, R.B. Luwor, M. Bilandzic, S. Nazaretian, K. Stenvers, J. Pyman, H. Zhu, E.W. Thompson, M.A. Quinn, J.K. Findlay, and N. Ahmed Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors PLoS One 7 10 2012 e46858
74. E. Lengyel Ovarian cancer development and metastasis Am. J. Pathol. 177 3 2010 1053 1064
75. K. Levanon, C. Crum, and R. Drapkin New insights into the pathogenesis of serous ovarian cancer and its clinical impact J. Clin. Oncol. 26 32 2008 5284 5293
76. K. Levanon, V. Ng, H.Y. Piao, Y. Zhang, M.C. Chang, M.H. Roh, D.W. Kindelberger, M.S. Hirsch, C.P. Crum, J.A. Marto, and R. Drapkin Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis Oncogene 29 8 2010 1103 1113
77. D. Liang, Y. Ma, J. Liu, C.G. Trope, R. Holm, J.M. Nesland, and Z. Suo The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells BMC Cancer 12 2012 201
78. K.A. Loffler, and P. Koopman Charting the course of ovarian development in vertebrates Int. J. Dev. Biol. 46 4 2002 503 510
79. D. Matei, R.E. Emerson, J. Schilder, N. Menning, L.A. Baldridge, C.S. Johnson, T. Breen, J. McClean, D. Stephens, C. Whalen, and G. Sutton Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier oncology group trial Cancer 113 4 2008 723 732
80. J.R. Matthews, O.J. Sansom, and A.R. Clarke Absolute requirement for STAT3 function in small-intestine crypt stem cell survival Cell Death Differ. 18 12 2011 1934 1943
81. S.M. McAuliffe, S.L. Morgan, G.A. Wyant, L.T. Tran, K.W. Muto, Y.S. Chen, K.T. Chin, J.C. Partridge, B.B. Poole, K.H. Cheng, J. Daggett Jr., K. Cullen, E. Kantoff, K. Hasselbatt, J. Berkowitz, M.G. Muto, R.S. Berkowitz, J.C. Aster, U.A. Matulonis, and D.M. Dinulescu Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy Proc. Nat. Acad. Sci. USA 109 43 2012 E2939 2948
82. K.Y.G. McLean, Y. Choi, N. Deng, K. Yang, S. Bai, L. Cabrera, E. Keller, L. McCauley, K.R. Cho, and R.J. Buckanocich Human ovarian carcinoma-associated mesenchymal stem cells regulate csancer stem cells and tumorigenesis via altered BMP production J. Clin. Invest. 121 8 2011 3206 3219
83. J.P. Medema Cancer stem cells: the challenges ahead Nat. Cell Biol. 15 4 2013 338 344
84. J.P. Medema, and L. Vermeulen Microenvironmental regulation of stem cells in intestinal homeostasis and cancer Nature 474 7351 2011 318 326
85. W.J. Murdoch, and J.F. Martinchick Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention Exp. Biol. Med. (Maywood) 229 6 2004 546 552
86. E.J. Nam, M. Lee, G.W. Yim, J.H. Kim, S. Kim, S.W. Kim, and Y.T. Kim MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line BMC Med. Genomics 5 2012 18
87. P.C. Nowell The clonal evolution of tumor cell populations Science 194 4260 1976 23 28
88. O.H. Ocana, R. Corcoles, A. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, and M.A. Nieto Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 Cancer Cell 22 6 2012 709 724
89. O. Oktem, and K. Oktay The ovary: anatomy and function throughout human life Ann. NY Acad. Sci. 1127 2008 1 9
90. T.G. Oliver, K.L. Mercer, L.C. Sayles, J.R. Burke, D. Mendus, K.S. Lovejoy, M.H. Cheng, A. Subramanian, D. Mu, S. Powers, D. Crowley, R.T. Bronson, C.A. Whittaker, A. Bhutkar, S.J. Lippard, T. Golub, J. Thomale, T. Jacks, and E.A. Sweet-Cordero Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer Genes Dev. 24 8 2010 837 852
91. C.K. Osborne, K. Hobbs, and G.M. Clark Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice Cancer Res. 45 1985 584 590
92. R.F. Ozols Systemic therapy for ovarian cancer: current status and new treatments Semin. Oncol. 33 2 Suppl 6 2006 S3 11
93. Y.T. Park, J.Y. Jeong, M.J. Lee, K.I. Kim, T.H. Kim, Y.D. Kwon, C. Lee, O.J. Kim, and H.J. An MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance J. Ovarian Res. 6 1 2013 18
94. S. Parte, D. Bhartiya, J. Telang, V. Daithankar, V. Salvi, K. Zaveri, and I. Hinduja Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary Stem Cells Dev. 20 8 2011 1451 1464
95. J. Pasquier, and A. Rafii Role of the microenvironment in ovarian cancer stem cell maintenance Biomed. Res. Int. 2013 2013 630782
96. P. Peng, Y. Yan, and S. Keng Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity Oncol. Rep. 25 3 2011 749 762
97. J. Permuth-Wey, and T.A. Sellers Epidemiology of ovarian cancer Methods Mol. Biol. 472 2009 413 437
98. H. Qi, X. Zheng, X. Yuan, S.C. Pflugfelder, and D.Q. Li Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium J. Cell Physiol. 225 1 2010 180 185
99. E. Quintana, M. Shackleton, M.S. Sabel, D.R. Fullen, T.M. Johnson, and S.J. Morrison Efficient tumour formation by single human melanoma cells Nature 456 7222 2008 593 598
100. L. Ricci-Vitiani, R. Pallini, M. Biffoni, M. Todaro, G. Invernici, T. Cenci, G. Maira, E.A. Parati, G. Stassi, L.M. Larocca, and R. De Maria Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 468 7325 2010 824 828
101. S. Runz, S. Keller, C. Rupp, A. Stoeck, Y. Issa, D. Koensgen, A. Mustea, J. Sehouli, G. Kristiansen, and P. Altevogt Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM Gynecol. Oncol. 107 3 2007 563 571
102. C. Samardzija, M. Quinn, J.K. Findlay, and N. Ahmed Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary J. Ovarian Res. 5 1 2012 37
103. I.G. Schauer, J. Zhang, Z. Xing, X. Guo, I. Mercado-Uribe, A.K. Sood, P. Huang, and J. Liu Interleukin-1beta Promotes Ovarian Tumorigenesis through a p53/NF-kappaB-Mediated Inflammatory Response in Stromal Fibroblasts Neoplasia 15 4 2013 409 420
104. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinberg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 6 2011 926 940
105. A.G. Schepers, H.J. Snippert, D.E. Stange, M. van den Born, J.H. van Es, M. van de Wetering, and H. Clevers Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas Science 337 6095 2012 730 735
106. R.J. Schilder, M.W. Sill, R.B. Lee, T.J. Shaw, M.K. Senterman, A.J. Klein-Szanto, Z. Miner, and B.C. Vanderhyden Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study J. Clin. Oncol. 26 20 2008 3418 3425
107. R.E. Scully Pathology of ovarian cancer precursors J. Cell Biochem. 23 1995 208 218
108. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 5 2009 822 829
109. Y. Shaked, E. Henke, J.M. Roodhart, P. Mancuso, M.H. Langenberg, M. Colleoni, L.G. Daenen, S. Man, P. Xu, U. Emmenegger, T. Tang, Z. Zhu, L. Witte, R.M. Strieter, F. Bertolini, E.E. Voest, R. Benezra, and R.S. Kerbel Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents Cancer Cell 14 3 2008 263 273
110. M.M. Sherry, A. Reeves, J.K. Wu, and B.H. Cochran STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells Stem Cells 27 10 2009 2383 2392
111. I.A. Shestopalov, and L.I. Zon Stem cells: the right neighbour Nature 481 7382 2012 453 455
112. B.D. Simons, and H. Clevers Strategies for homeostatic stem cell self-renewal in adult tissues Cell 145 6 2011 851 862
113. E.L. Spaeth, J.L. Dembinski, A.K. Sasser, K. Watson, A. Klopp, B. Hall, M. Andreeff, and F. Marini Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression PLoS One 4 4 2009 e4992
114. K.D. Steffensen, A.B. Alvero, Y. Yang, M. Waldstrom, I.P. Hu, J.C. Holmberg, D.A. Silasi, A. Jakobsen, T. Rutherford, and G. Mor Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer J. Oncol. 2011 2011 620523
115. A.D. Steg, K.S. Bevis, A.A. Katre, A. Ziebarth, Z.C. Dobbin, R.D. Alvarez, K. Zhang, M. Conner, and C.N. Landen Stem cell pathways contribute to clinical chemoresistance in ovarian cancer Clin. Cancer Res. 18 3 2012 869 881
116. J.M. Stewart, P.A. Shaw, C. Gedye, M.Q. Bernardini, B.G. Neel, and L.E. Ailles Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells Proc. Nat. Acad. Sci. USA 108 16 2011 6468 6473
117. P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, R. Foster, D. Dombkowski, F. Preffer, D.T. Maclaughlin, and P.K. Donahoe Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Proc. Nat. Acad. Sci. USA 103 30 2006 11154 11159
118. P.P. Szotek, H.L. Chang, K. Brennand, A. Fujino, R. Pieretti-Vanmarcke, C. Lo Celso, D. Dombkowski, F. Preffer, K.S. Cohen, J. Teixeira, and P.K. Donahoe Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics Proc. Nat. Acad. Sci. USA 105 34 2008 12469 12473
119. M. Todaro, M.P. Alea, A.B. Di Stefano, P. Cammareri, L. Vermeulen, F. Iovino, C. Tripodo, A. Russo, G. Gulotta, J.P. Medema, and G. Stassi Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 4 2007 389 402
120. R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, S. Lade, D.S. Johnson, M.K. Trivett, D. Etemadmoghadam, B. Locandro, N. Traficante, S. Fereday, J.A. Hung, Y.E. Chiew, I. Haviv, D. Gertig, A. DeFazio, and D.D. Bowtell Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin. Cancer Res. 14 16 2008 5198 5208
121. J.H. Tsai, J.L. Donaher, D.A. Murphy, S. Chau, and J. Yang Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis Cancer Cell 22 6 2012 725 736
122. J.H. van Es, T. Sato, M. van de Wetering, A. Lyubimova, A.N. Nee, A. Gregorieff, N. Sasaki, L. Zeinstra, M. van den Born, J. Korving, A.C. Martens, N. Barker, A. van Oudenaarden, and H. Clevers Dll1+ secretory progenitor cells revert to stem cells upon crypt damage Nat. Cell Biol. 14 10 2012 1099 1104
123. V. Vathipadiekal, D. Saxena, S.C. Mok, P.V. Hauschka, L. Ozbun, and M.J. Birrer Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer PLoS One 7 1 2012 e29079
124. S. Vaughan, J.I. Coward, R.C. Bast Jr., A. Berchuck, J.S. Berek, J.D. Brenton, G. Coukos, C.C. Crum, R. Drapkin, D. Etemadmoghadam, M. Friedlander, H. Gabra, S.B. Kaye, C.J. Lord, E. Lengyel, D.A. Levine, I.A. McNeish, U. Menon, G.B. Mills, K.P. Nephew, A.M. Oza, A.K. Sood, E.A. Stronach, H. Walczak, D.D. Bowtell, and I.F.R. Balkwil Rethinking ovarian cancer: recommendations for improving outcomes Nat. Rev. Cancer 11 10 2011 719 725
125. L. Vermeulen, M.R. Sprick, K. Kemper, G. Stassi, and J.P. Medema Cancer stem cells-old concepts, new insights Cell Death Differ. 15 6 2008 947 958
126. L. Vermeulen, E.M.F. De Sousa, M. van der Heijden, K. Cameron, J.H. de Jong, T. Borovski, J.B. Tuynman, M. Todaro, C. Merz, H. Rodermond, M.R. Sprick, K. Kemper, D.J. Richel, G. Stassi, and J.P. Medema Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat. Cell Biol. 12 5 2010 468 476
127. L. Vermeulen, F. de Sousa e Melo, D.J. Richel, and J.P. Medema The developing cancer stem-cell model: clinical challenges and opportunities Lancet Oncol. 13 2 2012 e83 89
128. I. Virant-Klun, N. Zech, P. Rozman, A. Vogler, B. Cvjeticanin, P. Klemenc, E. Malicev, and H. Meden-Vrtovec Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes Differentiation 76 8 2008 843 856
129. I. Virant-Klun, P. Rozman, B. Cvjeticanin, E. Vrtacnik-Bokal, S. Novakovic, T. Rulicke, P. Dovc, and H. Meden-Vrtovec Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes Stem Cells Dev. 18 1 2009 137 149
130. I. Virant-Klun, T. Skutella, M. Kubista, A. Vogler, J. Sinkovec, and H. Meden-Vrtovec Expression of pluripotency and oocyte-related genes in single putative stem cells from human adult ovarian surface epithelium cultured in vitro in the presence of follicular fluid Biomed. Res. Int. 2013 2013 861460
131. J.E. Visvader Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis Genes Dev. 23 22 2009 2563 2577
132. R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, and V. Tabar Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 7325 2010 829 833
133. R.T. Williams, W. den Besten, and C.J. Sherr Cytokine-dependent imatinib resistance in mouse BCR-ABL+Arf-null lymphoblastic leukemia Genes Dev. 21 18 2007 2283 2287
134. Q. Wu, R. Guo, M. Lin, B. Zhou, and Y. Wang MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2 Gynecol. Oncol. 122 1 2011 149 154
135. X. Yang, X. Lin, X. Zhong, S. Kaur, N. Li, S. Liang, H. Lassus, L. Wang, D. Katsaros, K. Montone, X. Zhao, Y. Zhang, R. Butzow, G. Coukos, and L. Zhang Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells Cancer Res. 70 22 2010 9463 9472
136. G. Yin, A.B. Alvero, V. Craveiro, J.C. Holmberg, H.H. Fu, M.K. Montagna, Y. Yang, I. Chefetz-Menaker, S. Nuti, M. Rossi, D.A. Silasi, T. Rutherford, and G. Mor Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential Oncogene 32 1 2012 39 49
137. A.G. Zeimet, D. Reimer, S. Sopper, M. Boesch, A. Martowicz, J. Roessler, A.M. Wiedemair, H. Rumpold, G. Untergasser, N. Concin, G. Hofstetter, E. Muller-Holzner, H. Fiegl, C. Marth, D. Wolf, M. Pesta, and J. Hatina Ovarian cancer stem cells Neoplasma 59 6 2012 747 755
138. S. Zhang, C. Balch, M.W. Chan, H.C. Lai, D. Matei, J.M. Schilder, P.S. Yan, T.H. Huang, and K.P. Nephew Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res. 68 11 2008 4311 4320
139. Y.V. Zhang, B.S. White, D.I. Shalloway, and T. Tumbar Stem cell dynamics in mouse hair follicles: a story from cell division counting and single cell lineage tracing Cell Cycle 9 8 2010 1504 1510
140. Y. Zhang, H. Tang, J. Cai, T. Zhang, J. Guo, D. Feng, and Z. Wang Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion Cancer Lett. 303 1 2011 47 55